SCHEMBL900332

SCHEMBL900332

CCS(=O)(=O)n1c(-c2cnccc2OC)nc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH3A1 P30838 3/20 0.43
LMNA P02545 3/20 0.43
HTT P42858 2/20 0.43
KDM4E B2RXH2 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
TSHR P16473 5/20 0.42
PKM P14618 1/20 0.42
SLC22A12 Q96S37 2/20 0.41
EGFR P00533 1/20 0.41
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
CXCL8 P10145 1/20 0.40
NOD1 Q9Y239 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28309320 0.73 KDM4E (0.50) ALDH3A1LMNAHTTKDM4ENPSR1
SCHEMBL970051 0.72 PDE10A (0.73) PDE10APDE2A
SCHEMBL899882 0.72 CYP17A1 (0.44) SLC22A12CYP1A2
SCHEMBL10304940 0.63 SLC22A12 (0.49) KDM4ETSHRSLC22A12MEN1CYP1A2
SCHEMBL23142381 0.63 ALDH1A1 (0.39) ALDH3A1LMNAHTTKDM4ENPSR1
SCHEMBL6510175 0.63 KDM4E (0.62) LMNAHTTKDM4ENPSR1PKM
SCHEMBL27892845 0.63 GSK3B (0.48) LMNAKDM4ETSHRSLC22A12GAA
SCHEMBL970311 0.63 PDE10A (0.81) PDE10APDE2A
SCHEMBL28444457 0.62 SLC22A12 (0.76) LMNASLC22A12CYP1A2CYP3A4CYP2C19
SCHEMBL28116715 0.61 ALDH3A1 (0.55) ALDH3A1LMNAHTTKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621913-A1 SUBSTITUTED BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS USEFUL AS CYP17 MODULATORS Bristol-Myers Squibb Company (US) 2013-08-07 EP disclosed
WO-2012044537-A1 SUBSTITUTED BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS USEFUL AS CYP17 MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-05 WO disclosed